These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34003926)

  • 1. Precision medicine in autoimmune diseases: fact or fiction.
    Toro-Domínguez D; Alarcón-Riquelme ME
    Rheumatology (Oxford); 2021 Sep; 60(9):3977-3985. PubMed ID: 34003926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-α: A key therapeutic target for multiple autoimmune rheumatic diseases.
    De Ceuninck F; Duguet F; Aussy A; Laigle L; Moingeon P
    Drug Discov Today; 2021 Oct; 26(10):2465-2473. PubMed ID: 34224903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized medicine. Closing the gap between knowledge and clinical practice.
    Anaya JM; Duarte-Rey C; Sarmiento-Monroy JC; Bardey D; Castiblanco J; Rojas-Villarraga A
    Autoimmun Rev; 2016 Aug; 15(8):833-42. PubMed ID: 27302209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus.
    Catalina MD; Owen KA; Labonte AC; Grammer AC; Lipsky PE
    J Autoimmun; 2020 Jun; 110():102359. PubMed ID: 31806421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from precision medicine in rheumatology.
    Wampler Muskardin TL; Paredes JL; Appenzeller S; Niewold TB
    Mult Scler; 2020 Apr; 26(5):533-539. PubMed ID: 31965913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferon in organ-targeted autoimmune and inflammatory diseases.
    Crow MK
    Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S5. PubMed ID: 21303493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical update on the significance of the gut microbiota in systemic autoimmunity.
    Rosser EC; Mauri C
    J Autoimmun; 2016 Nov; 74():85-93. PubMed ID: 27481556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Variation and Precision Medicine in Systemic Lupus Erythematosus.
    Yang R; Hu Y; Bo L
    Methods Mol Biol; 2020; 2204():193-203. PubMed ID: 32710326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dawn of Precision Medicine in Psoriatic Arthritis.
    Miyagawa I; Tanaka Y
    Front Med (Lausanne); 2022; 9():851892. PubMed ID: 35372404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of type I interferon in systemic autoimmune diseases.
    Crow MK; Olferiev M; Kirou KA
    Transl Res; 2015 Feb; 165(2):296-305. PubMed ID: 25468480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2X7 receptor: A potential therapeutic target for autoimmune diseases.
    Cao F; Hu LQ; Yao SR; Hu Y; Wang DG; Fan YG; Pan GX; Tao SS; Zhang Q; Pan HF; Wu GC
    Autoimmun Rev; 2019 Aug; 18(8):767-777. PubMed ID: 31181327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
    Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
    Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.
    Tuller T; Atar S; Ruppin E; Gurevich M; Achiron A
    Genes Immun; 2013 Mar; 14(2):67-82. PubMed ID: 23190644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.
    Bilsborrow JB; Doherty E; Tilstam PV; Bucala R
    Expert Opin Ther Targets; 2019 Sep; 23(9):733-744. PubMed ID: 31414920
    [No Abstract]   [Full Text] [Related]  

  • 15. IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    Rodríguez-Carrio J; López P; Alperi-López M; Caminal-Montero L; Ballina-García FJ; Suárez A
    Front Immunol; 2018; 9():3085. PubMed ID: 30666255
    [No Abstract]   [Full Text] [Related]  

  • 16. The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases.
    Mirzaei R; Zamani F; Hajibaba M; Rasouli-Saravani A; Noroozbeygi M; Gorgani M; Hosseini-Fard SR; Jalalifar S; Ajdarkosh H; Abedi SH; Keyvani H; Karampoor S
    J Neuroimmunol; 2021 Sep; 358():577640. PubMed ID: 34224949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipidomics in autoimmune diseases with main focus on systemic lupus erythematosus.
    Ferreira HB; Pereira AM; Melo T; Paiva A; Domingues MR
    J Pharm Biomed Anal; 2019 Sep; 174():386-395. PubMed ID: 31207360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
    Long H; Yin H; Wang L; Gershwin ME; Lu Q
    J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not Available].
    Guffroy A; Martin T; Gies V
    Rev Med Interne; 2020 Oct; 41(10):649-652. PubMed ID: 32768267
    [No Abstract]   [Full Text] [Related]  

  • 20. Autophagy and Autoimmune Diseases.
    Jin M; Zhang Y
    Adv Exp Med Biol; 2020; 1207():405-408. PubMed ID: 32671763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.